Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Ventana Settle IP Litigation

NEW YORK (GenomeWeb News) – Qiagen and Ventana Medical Systems jointly announced today that they have agreed to settle litigation regarding two expired patents covering human papillomavirus probes.
The firms said that they had mutually agreed to terms on Dec. 15 settling litigation of the expired patents, US Nos. 4,849,331 and 4,849,332.
Under terms of the settlement, Ventana agreed to pay Qiagen an undisclosed sum. In return, Qiagen acknowledged that pursuant to an asset purchase agreement signed Sept. 23, 2002, Ventana has lawfully succeeded to certain rights held by Beckman Coulter under a cross-licensing pact originally entered into between Institut Pasteur and Life Technologies and a separate agreement between Institut Pasteur and Beckman.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.